ESC 365 - Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?

ESC Premium Access

Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?

Session: Poster session 1 - Risk stratification and prognosis after TAVI

Topic: Aortic valve disease

Speaker: Mrs A. Stundl (Bonn, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Mrs Anja Stundl

University hospital Bonn, Bonn (Germany)

0 follower

10 more presentations in this session

Effect of transcatheter aortic valve implantation (TAVI) in acquired von Willebrand syndrome and molecular analysis of high-molecular-weight multimers.

Speaker: Doctor M. Perrone (Rome, IT)

Combination of pre-existing atrial fibrillation and coronary artery disease associates with poor outcome in patients who undergo TAVI

Speaker: Doctor H. Hioki (Tokyo, JP)

Transcatheter aortic valve replacement alters expression levels of circulating myocardial microRNAs

Speaker: Doctor F. Jansen (Bonn, DE)

Peri-procedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after tavi

Speaker: Mrs A. Stundl (Bonn, DE)

Impact of diastolic dysfunction severity on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Speaker: Professor R. Waksman (Washington, DC, US)

Access the full session

Poster session 1 - Risk stratification and prognosis after TAVI

Speakers: Mrs A. Stundl, Doctor M. Perrone, Doctor H. Hioki, Doctor F. Jansen, Mrs A. Stundl...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources